Health Press Release – Newsletter for October 14, 2010
Thursday, October 14, 2010
Goodmans Solicitors Rebrand
LIVERPOOL, England, October 13, 2010 – Leading medical negligence and personal injury solicitors, Goodmans Law
(www.goodmanslaw.co.uk/) has completed a rebranding process to
complete their transition to a specialist medical negligence and personal
injury law firm.
Goodmans Law, based in Liverpool, has evolved into one of the largest
specialist firms in this area of law. Goodmans … Read : Goodmans Solicitors Rebrand.
Shire Acquires 99.21% of the Shares of Movetis N.V. and Announces Commencement of Squeeze-Out Tender Period
DUBLIN, October 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its wholly owned subsidiary Shire
Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on
October 12, 2010, following a successful tender offer launched in September
2010.
As previously announced, Shire will proceed with a …. Read the original article : here.
New Line of Neonatal Blood Pressure Supplies Demonstrates Philips’ Commitment to Patient Safety
ANDOVER, Massachusetts, October 13, 2010 – Today Royal Philips Electronics (NYSE: PHG, AEX: PHI) launched its newest
line of neonatal blood pressure solutions. As the global leader in neonatal
monitoring, Philips designed the new line of neonatal cuffs, air hoses, and
upgrade kits specifically to prevent tragic misconnection errors that can
cause harm to the most vulnerable of … Read more : New Line of Neonatal Blood Pressure Supplies Demonstrates Philips' Commitment to Patient Safety.
Cell Biosciences to Acquire Convergent Bioscience
SANTA CLARA, California, October 13, 2010 – Cell Biosciences, Inc. today announced that it has entered into a
definitive agreement to acquire Convergent Bioscience Ltd. for approximately
U.S. $12 million in cash. The transaction is expected to close by the end of
October, 2010.
Convergent Bioscience was founded in 1995 and employs 45 people,
primarily …. Original article : Cell Biosciences to Acquire Convergent Bioscience.
Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters
SOUDERTON, Pennsylvania, October 13, 2010 – Almac announced today that its Clinical Technologies division has
successfully moved into the Almac Group's new North American Headquarters.
After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008,
the drug development firm has now completed the first phase of relocating
employees from three Almac business units to the … Read more »»».
Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
SAN FRANCISCO, October 13, 2010 – Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and
"The Pink Sheet," today announced the agenda for Windhover's 2nd PharmAsia
Summit
(www.windhover.com/windhover/content/conferences/pharmasia.aspx)
(Oct. 25-26). This year's Summit will bring top biopharma leaders from
Asia and the U.S. to San Francisco to share what works and what doesn't in
China, India, Japan and the …. Original article : Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco.
Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research
OOSTERHOUT, Netherlands, October 13, 2010 – Luminex Corporation (Nasdaq: LMNX), today announced that it will host
Planet xMAP Europe 2010, its annual European multiplexing technology
symposium, October 20-21, 2010, at The Hofburg in Vienna, Austria. The event
will feature scientific … Read more >>>.
Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award
LONDON, October 13, 2010 – The 2010 Frost & Sullivan Europe Product Line Strategy Award in
Fingerprint Verification Components and Systems is presented to Fingerprint
Cards AB (FPC).
(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
"For more than a decade, FPC has been operating in the biometrics
industry with the prime … Read more : Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award.
PneumRx, Inc. Announces CE Mark Approval for Its RePneu(R) Lung Volume Reduction Coil (LVRC(TM)) System
MOUNTAIN VIEW, California, October 13, 2010 – PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to
bringing innovation and improvements to the treatment of lung disease, today
announced that it has received CE Mark approval for its RePneu Lung Volume
Reduction Coil (LVRC) System to treat the later stages of emphysema.
The RePneu LVRC … Read more >>>.
550 People Across Europe Will Die Today From a Preventable Lung Disease
On World Spirometry Day, Doctors Urge Regular "MOT Tests for the Lungs"
LONDON, October 14, 2010 – With new data revealing 23 Europeans die each hour[i] from a preventable
lung condition, the European Respiratory Society (ERS) is calling on people
across Europe to get their lungs tested on the first ever World Spirometry
Day – 14th October.
…. Read the original article : 550 People Across Europe Will Die Today From a Preventable Lung Disease.
Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver
Poster presentation scheduled at AASLD November 2nd
SAN DIEGO, October 14, 2010 – Vital Therapies, Inc., (VTI) today announced that a poster is being
presented at the American Association for the Study of Liver Diseases (AASLD)
meeting in Boston on Tuesday, November 2nd. It confirms that previously
reported findings of improved transplant free survival (TFS) in Chinese
subjects with … Original article on : Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver.